Next Article in Journal
Effect of Ultraviolet-C Radiation and Melatonin Stress on Biosynthesis of Antioxidant and Antidiabetic Metabolites Produced in In Vitro Callus Cultures of Lepidium sativum L.
Next Article in Special Issue
Hidden Aggregation Hot-Spots on Human Apolipoprotein E: A Structural Study
Previous Article in Journal
Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion
Previous Article in Special Issue
Development of a Soy Protein Hydrolysate with an Antihypertensive Effect
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prediction of Bioactive Peptides from Chlorella sorokiniana Proteins Using Proteomic Techniques in Combination with Bioinformatics Analyses

by
Lhumen A. Tejano
1,
Jose P. Peralta
1,
Encarnacion Emilia S. Yap
1,
Fenny Crista A. Panjaitan
2 and
Yu-Wei Chang
2,*
1
Institute of Fish Processing Technology, College of Fisheries and Ocean Sciences, University of the Philippines Visayas, Miagao 5023, Iloilo, Philippines
2
Department of Food Science, National Taiwan Ocean University, Keelung 202, Taiwan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(7), 1786; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20071786
Submission received: 20 February 2019 / Revised: 3 April 2019 / Accepted: 9 April 2019 / Published: 11 April 2019
(This article belongs to the Special Issue Peptides for Health Benefits 2019)

Abstract

:
Chlorella is one of the most nutritionally important microalgae with high protein content and can be a good source of potential bioactive peptides. In the current study, isolated proteins from Chlorella sorokiniana were subjected to in silico analysis to predict potential peptides with biological activities. Molecular characteristics of proteins were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and proteomics techniques. A total of eight proteins were identified by proteomics techniques from 10 protein bands of the SDS-PAGE. The predictive result by BIOPEP’s profile of bioactive peptides tools suggested that proteins of C. sorokiniana have the highest number of dipeptidyl peptidase-IV (DPP IV) inhibitors, with high occurrence of other bioactive peptides such as angiotensin-I converting enzyme (ACE) inhibitor, glucose uptake stimulant, antioxidant, regulating, anti-amnestic and antithrombotic peptides. In silico analysis of enzymatic hydrolysis revealed that pepsin (pH > 2), bromelain and papain were proteases that can release relatively larger quantity of bioactive peptides. In addition, combinations of different enzymes in hydrolysis were observed to dispense higher numbers of bioactive peptides from proteins compared to using individual proteases. Results suggest the potential of protein isolated from C. sorokiniana could be a source of high value products with pharmaceutical and nutraceutical application potential.

Graphical Abstract

1. Introduction

Microalgae are eukaryotic unicellular organisms that grow easily with inexpensive substrates. Therefore, they are considered to be economical and effective raw materials in industry [1]. Many studies have been conducted to utilize microalgae as useful products. Most of them majorly focused on the potential of microalgae for biofuel production due to their lipid content and abundant availability [1,2]. However, due to the increasing population and demand for protein, there is a call to further utilize microalgae as protein sources to shift away from animal proteins.
Microalgae have been known as one of many promising alternative plants for proteins as they offer up to 50% (w/w) of protein [3] with a well-balanced amino acid profile required for the nutrition of human beings [1,4]. Several studies have reported the biological activities of various microalgae protein hydrolysates, including immunostimulant and antitumor activities from C. sorokiniana [5,6], angiotensin-I converting enzyme (ACE) inhibitory and hypotensive activities from Chlorella vulgaris [7,8] and Nannochloropsis oculata [9], antioxidant effects from Navicula incerta [10] and Chlorella ellipsoidea [11], anti-inflammatory effects from Spirulina maxima [12] and antibacterial property from Spirulina platensis [13]. From Chlorella sorokiniana, Lin et al. [14] were able to purify and identify four active peptides with high ACE inhibitory effects. A variety of other compounds were also detected from microalgae which show certain usefulness for human and animals. Morgese et al. [15] previously reported the beneficial effect of omega (ω)-3 and ω-6 polyunsaturated fatty acids (PUFAs) from Chlorella sorokiniana on the emotional, cognitive and social behavior in rats. Talero et al. [16] also reviewed bioactive compounds of microalgae that give the chemopreventive effect on chronic inflammation and cancer. Corresponding to those findings, the exploration of biological activities from microalgae has gained significant attention with regard to its health-promoting properties related to bioactive compounds. Therefore, further observations are still needed to identify more bioactive peptides from C. sorokiniana, including dipeptidyl peptidase-IV (DPP IV) inhibitory peptides, ACE-inhibitory peptides and antioxidant peptides.
With the advancements in protein analysis, techniques for protein identification and predictive analysis of potential bioactive peptides have been established. Proteomics techniques have been widely used to analyze proteins presented in protein sample [17]. Moreover, mass spectrometry (MS)-based proteomics have been successfully applied in researches to identify protein from complex materials, including protein characterization of chickpea and oat seeds [18], fish authentication [19], species identification of spoilage and pathogenic bacteria [20], and protein characterization of tilapia processing co-products [21]. Once the sequences of protein are obtained, a bioinformatics tool such as the BIOPEP-UWM database is used to predict bioactive peptides composed in protein sequences [22,23]. Bioinformatics, also known as in silico technique, is a computational method used to estimate bioactive peptides from the known protein sequences [24]. It also allows performing the simulation of enzymatic hydrolysis using proteases to predict bioactive peptides theoretically released from the intact protein sequences [25,26,27].
The application of proteomics coupled with BIOPEP-UWM will be able to deliver a rapid method to identify and characterize proteins. This technique will reduce cost and time regarding the prediction of the potential bioactive peptides. Thus, this study generally aimed to characterize the isolated proteins from C. sorokiniana using in-gel digestion and proteomics techniques. Furthermore, the BIOPEP-UWM database tool was used to predict the potential bioactive peptides derived from the identified proteins of C. sorokiniana.

2. Results and Discussion

2.1. Identified Proteins of C. sorokiniana

The protein content of C. sorokiniana isolates was 65.08 ± 0.88% with a yield of 4.40% (w/w initial biomass dry basis). A total of the 10 distinct protein bands of C. sorokiniana proteins were observed in 12% acrylamide gel (Figure 1). These labeled protein bands (A–J) were used for the in-gel digestion and subsequently analyzed using nanoLC–nanoESI MS/MS. The molecular weights (MWs) of the proteins estimated by SDS-PAGE were 109.02 (A), 72.08 (B), 54.15 (C), 45.72 (D), 38.33 (E), 29.04 (F), 24.96 (G), 21.13 (H), 16.59 (I), and 7.82 (J). Eight protein hits were discovered from the selected bands in the NCBI database namely, chloroplast rubisco activase, 50S ribosomal protein L7/L12 (chloroplast), phosphoglycerate kinase, Fe-superoxide dismutase, heat shock protein 70, ATP synthase subunit beta (chloroplast), elongation factor 2, partial, and V-type H+ ATPase subunit A, partial. The protein hits, accession number from the NCBI database, length of amino acid (AA), and molecular weight of the band reported in NCBI database and estimated by SDS-PAGE were presented in Table 1. The estimated MWs by SDS-PAGE were comparable to the theoretical molecular weights reported in NCBI database except for elongation factor 2, partial and V-type H+ ATPase Subunit A, partial.
C. sorokiniana is a freshwater green algae species with high protein content [28]. This species of genus Chlorella was originally called as C. pyrenoidosa [29]. The NCBI database revealed a total of 20,925 proteins from the C. sorokiniana. Most of them are enzymes responsible for various cell functions. According to the nanoLC–nanoESI MS/MS data, eight protein hits from the NCBI database corresponded to the proteins of C. sorokiniana. Phosphoglycerate kinase (Auxenochlorella pyrenoidosa, NCBI accession number: AKP17751.1) was detected in all selected protein bands in the SDS-PAGE. Watson et al. [30] stated that phosphoglycerate kinase derived from various protein sources are all monomers with MWs around 45 kDa. Moreover, their amino acid composition and catalytic functions are similar [31]. The reference molecular weight for phosphoglycerate kinase from NCBI database was 49.13 kDa, thus phosphoglycerate kinase found in band D (45.72 kDa) was used for further analyses. The possibility of having the same single protein in different bands is high since proteins are denatured and separated in SDS-PAGE. In addition, protein hits discovered by the Mascot database were identified based on the matched tryptic peptides detected by mass spectrometry.

2.2. Identified Tryptic Peptides from C. sorokiniana Proteins

Tryptic peptides derived from the identified proteins of C. sorokiniana by in-gel digestion were evaluated by nanoLC–nanoESI MS/MS analysis. Those tryptic peptides identified through mass spectrometry were peptides matching with protein hits in the Mascot database. Tryptic peptides are generated by trypsin through in-gel digestion process which is part of proteomics technique. The result of the MS/MS ion search for the tryptic digests revealed that all the tryptic peptides from the identified proteins were doubly and triply charged. Figure 2 and Figure 3 present the representative spectra of the doubly and triply charged peptides from the identified proteins of C. sorokiniana by proteomics analysis.
Figure 2 illustrates the doubly charged tryptic peptide of C. sorokiniana of protein band D (Figure 1), with observed signal m/z 1053.01 marked in red box representing a doubly charged peptide (with adjacent signal difference of 0.50, insert A), and nanoLC–nanoESI MS/MS fragmentation spectra of NFNNIEDGFYISPAFLDK found in chloroplast rubisco activase (NCBI accession no. AEL29575.1) represented in insert B. Figure 3 illustrates the triply charged tryptic peptide also found in the same identified protein of the same protein band D. The observed signal was m/z 618.66, also marked in red box demonstrating a triply charged peptide (with adjacent signal difference of 0.33, insert A), and nanoLC–nanoESI MS/MS fragmentation spectra of tryptic peptide LVDAFPGQSIDFFGALR found in chloroplast rubisco activase (NCBI accession no. AEL29575.1) is illustrated in insert B.
In the identification of proteins by proteomics analysis, trypsin is usually used to digest proteins in the gel [32]. Trypsin hydrolyzes protein specifically at the C-terminus of the carboxyl side of the amino acids arginine or lysine, but poorly when lysine and arginine are followed by proline. With this perspective, the tryptic peptides are either doubly or triply charged in ESI since the amino terminal residues are basic which explains the result of the MS/MS ion search [33].

2.3. Potential Bioactive Peptides from Identified Proteins in C. sorokiniana

Potential bioactive peptides presented in identified proteins of C. sorokiniana were investigated using the BIOPEP-UWM database. Amino acid sequences of six proteins, namely chloroplast rubisco activase, 50s ribosomal protein l7/l12 (chloroplast), phosphoglycerate kinase, Fe-superoxide dismutase, heat shock protein 70 and ATP synthase subunit beta (chloroplast), were chosen as they are found to be relatively abundant components of C. sorokiniana proteins found in SDS-PAGE based on the results. Moreover, they also corresponded to the estimated molecular weights in the NCBI database (Table 1). The profile of the potential bioactive peptides, their biological activities (ACE inhibitory, antioxidant, anti-amnestic, antithrombotic, stimulating, regulating, DPP IV inhibitory), and frequencies are summarized in Table 2. Results revealed that most of the potential bioactive peptides were dipeptides or tripeptides with multiple biological activities. The number of those bioactive peptides was identified based on the amino acid sequences which were predicted to become potential bioactive peptides. The BIOPEP database displays peptides with their bioactivities from inputted protein sequences corresponding to the information in the database.
Chloroplast rubisco activase (NCBI accession no. AEL29575.1) and phosphoglycerate kinase (NCBI accession no. AKP17751.1) were chosen to illustrate the profile of bioactive peptides within in the protein (Figure 4 and Figure 5) because they appeared to be relatively abundant and were found in almost all picked bands in SDS-PAGE. As shown in Figure 4, the molecular weights of the tryptic peptides corresponded to the identified tryptic peptide at amino acid positions 100–117, 132–144, 158–181, 187–145, 149–213, 255–273, 290–304, and 310–326 (matched tryptic peptides shown in red letters) in the chloroplast rubisco activase amino acid sequence. BIOPEP-UWM analysis results exhibited that potential bioactive peptides encrypted in chloroplast rubisco activase amino acid sequence were mostly DPP IV inhibitors (with 250 peptide fragments, marked with an orange line) and ACE inhibitors (with 187 peptide fragments, marked with a green line). Other bioactive peptides found were 18 antioxidant, 3 anti-amnestic, 2 antithrombotic, 18 stimulant and 3 regulatory peptides. Some bioactive peptides have multiple activities such as VPL, WG, LA, IR, PG, VY, and KP.
On the other hand, Figure 5 shows the molecular weights of the tryptic peptides in phosphoglycerate kinase which corresponds to the theoretical tryptic peptides at amino acid positions 232–244, 258–268, 285–298, 303–313, 383–411, and 436–465 (matched tryptic peptides shown in red letters). There were 297 DPP IV inhibitor, 224 ACE inhibitor, 23 antioxidant, 33 stimulant, 5 anti-amnetic, 4 antithrombotic, and 6 regulatory peptides embedded in the amino acid sequence of phosphoglycerate kinase. Moreover, the profiles of the bioactive peptides of 50s ribosomal protein l7/l12 (chloroplast), Fe-superoxide dismutase, heat shock protein 70 and ATP synthase subunit beta (chloroplast) also show the presence of the above mentioned bioactive peptides in these proteins, except that Fe-superoxide dismutase does not show anti-amnestic, antithrombotic, or regulating peptides. In all the proteins, DPP IV and ACE inhibitors were the most abundant bioactive peptides.
The amino acid composition and sequence of the proteins greatly determines the presence of these bioactive peptides. Results also revealed that most of the DPP IV peptides present in the identified proteins had proline (P), alanine (A), glycine (G), valine (V) and leucine (L) amino acid residues. DPP IV preferably cleaves dipeptides with proline and alanine residues at the N-terminal side of the peptide [34]. It also has relatively lower cleavage rates with serine, glycine, leucine, and valine [35,36]. Moreover, the presence of basic and hydrophobic amino acids at the N-terminal side of the peptides could enhance the cleavage susceptibility of the substrate [34,37]. DPP IV inhibitors were also reported from various protein sources by in silico approach including barley, canola, oat, soybean, wheat, quinoa, chicken egg, bovine milk, bovine meat, pig, tuna, Atlantic salmon, chum salmon, tilapia skin and frame, and palmaria palmate [21,27,38,39,40]. On the other hand, the abundance of ACE inhibitory peptides in the identified proteins might have also been influenced by the amino acid compositions of the proteins. The presence of amino acid residues such as phenylalanine (F), tyrosine (Y), tryptophan (W), or proline (P) in at the C-terminal side of the peptides have been reported to exhibit high potent ACE inhibitory activity [41,42,43,44,45]. The adjacent amino acid residue of proline can also influence the potency of the ACE inhibitor, which is usually enhanced by hydrophobic amino acids [46]. In silico analysis of different proteins revealed the abundance of ACE inhibitors embedded in various protein sequences [47,48,49]. In previous studies, some amino acid sequences of ACE inhibitory peptides from C. sorokiniana were discovered. Lin et al. [14] reported IC50 values of WV, VW, IW, and LW were 307.61, 0.58, 0.50, and 1.11 µM, respectively. Moreover, C. sorokiniana protein hydrolysates could reduce systolic and diastolic blood pressure at 20 and 21 mm Hg, respectively. Suetsuna and Chen [8] also mentioned several amino acid sequences generated potential antihypertensive activity through oral administration, such as IVVE (IC50: 315.3 μM), AFL (IC50: 63.8 μM), FAL (IC50: 26.3 μM), AEL (IC50: 57.1 μM), and VVPPA (IC50: 79.5 μM) from C. vulgaris; IAE (IC50: 34.7 μM), FAL, AEL, IAPG (IC50: 11.4 μM), and VAF (IC50: 35.8 μM) from S. platensis. Those findings showed that ACE inhibitory peptides predicted through in silico analysis obviously possessed potential antihypertensive activity through in vitro and in vivo analysis.
For many years now, in silico analysis has been successfully used to predict the potential application of various proteins as a source of bioactive peptides [22]. It provides sufficient information for determining the potential biological activity of proteins which is much faster than conventional methods [21]. The results of the in silico analysis by BIOPEP-UWM suggest the potential of C. sorokiniana proteins for pharmaceutical application as demonstrated by its bioactivities. These peptides in the intact proteins are inactive and need to be released in order to perform their functions [50]. The prediction of the potential bioactivities of the proteins after digestion by various proteases can be conducted by the BIOPEP-UWM database tool.

2.4. Prediction of Potential Bioactive Peptides after Protease Cleavage using BIOPEP-UWM Tool

Identified proteins such as chloroplast rubisco activase, phosphoglycerate kinase, Fe-superoxide dismutase, heat shock protein 70 and ATP synthase subunit beta (chloroplast) were further analyzed using the “enzyme action” tool in BIOPEP-UWM database; these proteins showed the most numbers of bioactivities from their profiles of bioactive peptides (Table 2). Results of the 15 simulations of enzymatic hydrolysis for each protein sequence are presented in Table 3. The table shows the number of bioactive peptides with specific bioactivities after hydrolysis of the individual proteins by various proteases. The results revealed that DPP IV inhibitory peptides were observed to be dominantly produced from the selected proteins using different proteases. ACE inhibitory peptides were also released in relatively high numbers but lower than DPP IV. This information is in concurrence with the profile of the potential bioactive peptides from the proteins in Table 2. Bromelain, papain, ficin and pepsin (pH > 2) were the individual proteases that released the most diverse and large number peptides with certain biological activities from all the selected proteins. Meanwhile, trypsin had the lowest number of bioactive peptides release after in silico hydrolysis. Trypsin is the most commonly used enzyme in proteomics approach [32], however, in the in silico analysis, it did not release significant numbers of potential bioactive peptides. Nonetheless, based on the results, other single action enzymes could also release relatively high numbers of bioactive peptides. The use of a combination of enzymes in hydrolysis is also offered by the BIOPEP-UWM database. A combination of two to a maximum of three enzymes could be utilized in the hydrolysis simulation of the proteins. The combination of three enzymes (trypsin, α-chymotrypsin, and pepsin) had been identified to produce potential anti-inflammatory peptides in microalgae, such as LDAVNR and MMLDF [12]. Table 3 reveals that the use of combined action of two to three enzymes could actually lead to the release of higher numbers of bioactive peptides from the selected proteins. This implies a greater effectiveness of using the combined action of enzymes in cleaving peptide bonds than the single action enzyme, except for pepsin which has almost the same number of released peptides with the combined enzyme action. Pepsin has been reported from several in vitro studies to produce various bioactive peptides from microalgae hydrolysates such as an ACE inhibitor and antioxidant peptides. Samarakoon et al. [9] mentioned that pepsin generated more potential ACE inhibitory peptides compared to other proteases, such as GMNNLTP (IC50: 123 μM) and LEQ (IC50: 173 μM). Ko et al. [11] also identified LNGDVW from peptic hydrolysates possessed strong scavenged peroxyl, DPPH and hydroxyl radicals at the IC50 values of 0.02, 0.92 and 1.42 mM, respectively. Moreover, peptic hydrolysates from microalgae efficiently generated strong antioxidant activities [51,52].
Furthermore, in comparison to the other three proteins, ATP synthase subunit beta demonstrated higher tendency to release more bioactive peptides using the different proteases. However, these theoretically produced bioactive peptides may not always have a comparable function with the in vitro and in vivo analyses, thus further study of these peptides using in vitro and in vivo studies should be conducted. Nevertheless, the BIOPEP’s “enzyme action” tool was able to provide reference information on the possible bioactive peptides that could be released from the selected proteins using various proteases.

3. Materials and Methods

3.1. Materials

The microalgae, C. sorokiniana was obtained from the Taiwan Chlorella Manufacturing Co., Ltd. (Taipei, Taiwan), considered as the largest producer of Chlorella every year with an average production of 400 tons of dried biomass [1]. All reagents and chemicals used were analytical grade.

3.2. Protein Isolation

The protein isolation process was adapted from the procedure of Parimi et al. [53] with modifications. Briefly, C. sorokiniana biomass slurry at 1:16 (w/v) ratio was prepared. Sonication for 1 h was done to the slurry for pretreatment and subsequent alkaline protein extraction by solubilization at 11.38 using 2 M NaOH for 35 min with stirring. It was followed by isoelectric precipitation of the supernatant at 4.01 with 1M HCL and stirred for 60 min. Centrifugation at 8750× g for 35 min was done for the solid-liquid separation during the solubilization and precipitation steps. The protein isolate was lyophilized and stored at −20 °C until further use. The modified Lowry method [54] was used to determine the protein content of the isolate.

3.3. SDS-PAGE Analysis

The SDS-PAGE was performed according to a method described by Schägger and Von Jagow [55] 4% stacking gel (w/v) and 12% polyacrylamide gel (w/v). 10 milligrams of protein isolate was dissolved in 1 mL of denaturant sample buffer (0.5 M Tris-HCl pH 6.8, glycerol, 10% SDS, w/v, 0.5% bromophenol blue, w/v, β-mercaptoethanol), and heated at 95 °C. Then, 10 µL of the sample was loaded to the sample wells. Protein separation was carried at 80 V for 30 min followed by 110 V for 90 min for the resolving gel using a Mini Protean II unit (Bio-Rad Laboratories, Hercules, CA, USA). The gel was stained for 40 min with Brilliant Blue (Bio-Rad, Coomassie R250). Destaining of the gel was done three times using water/methanol/acetic acid (7/2/1, v/v/v) for 15 min each cycle with shaking using an orbital shaker (Fristek S10, Taichung city, Taiwan). Estimation of the molecular mass of proteins was done using molecular protein mass marker (250 to 10 kDa, Bio-Rad) loaded at 5 uL in the sample well. The gels was scanned with E-Box VX5 (Vilber Lourmat, Paris, France) and the analysis of the captured image was done using Vision Capt software (V16.08a, Vilber Lourmat, Paris, France).

3.4. Proteomics Techniques

3.4.1. In-Gel Tryptic Digestion

The following proteomics technique experiments were carried out in Academia Sinica, Nangang District, Taipei City, Taiwan. Proteomics techniques were adapted from the methods described by Chang et al. [18]. Gel slice and in-gel digestion were performed using the combined modified methods of Rosenfeld et al. [56] and Shevchenko et al. [32]. Briefly, 10 intensive colored protein bands were excised from the SDS-PAGE gel for the in-gel digestion. The gel pieces were destained with 25 mM amonium bicarbonate (ABC)/ 50% acetonitrile (ACN) solution in a microcentrifuge PP tubes. The destained gel pieces were added with 100 µL of 50 mM dithioerythreitol (DTE) / 25 mM ABC and soaked at 37 °C for 1 h. The tubes were centrifuged and the DTE solution was removed. Then, the gel pieces were added with 100 µL of 100 mM iodoacetamide (IAM) / 25 mM ABC and soaked at room temperature in a dark place for 1 h for the alkylation step. The IAM solution was removed after centrifugation. Washing of the gel pieces was done by soaking in 200 µL of 50% ACN / 25 mM ABC for 15 min. The solution was removed after centrifugation and the process was repeated four times. The gel slices were then soaked in 100 µL of 100% ACN for 5 min, repeated twice, and the solution was discarded after centrifugation. The gel slices were dried for 5 min using Speed Vac (Thermo Scientific, Waltham, MA, USA). Trypsin digestion followed by adding Lys-C / 25 mM ABC (enzyme:protein, 1:50) and incubating the mixture for 1 h at 37 °C. Afterwards, the same amount of trypsin was added and incubated for 16 h at 37 °C. Afterwards, the extraction of the tryptic peptides was done with 50 µL of 50% ACN/ 5% trifluoroacetic acid (TFA). The peptide extracts were transferred to new tubes and dried Speed Vac (Thermo Scientific, Waltham, MA, USA). Finally, the peptide extracts were purified using C18 Zip-Tip. The purified peptide extracts were used for the nanoLC–nanoESI MS/MS analysis.

3.4.2. Nanoliquid Chromatography–Nanoelectrospray Ionization Tandem Mass Spectrometry (NanoLC–nanoESI MS/MS) Analysis

Dried tryptic peptide digest was subjected to nanoLC−nanoESI MS/MS analysis using a nanoAcquity system (Waters, Milford, MA, USA) connected to the LTQ Orbitrap Velos hybrid mass spectrometer (Thermo Electron, Bremen, Germany) equipped with a PicoView nanospray interface (New Objective, Woburn, MA). The tryptic peptide mixtures were loaded onto a 75 µm ID, 25 cm length C18 BEH column (Waters, Milford, MA) packed with 1.7 µm particles with a pore width of 130 Å. Separation was performed using a segmented gradient in 60 min from 5 to 35% solvent B (acetonitrile with 0.1% formic acid) at 300 nL/min flow rate and at 35 °C column temperature. Solvent A was 0.1% formic acid in water (v/v). The mass spectrometer was operated in the data-dependent mode. In brief, the orbitrap (m/z 350–1600) with the resolution set to 60 K at m/z 400 and automatic gain control (AGC) target at 106 was used to obtain the survey full scan MS spectra. The 20 most intense ions were sequentially isolated for collision-induced dissociation (CID) MS/MS fragmentation and detection in the linear ion trap (AGC target at 10,000) with previously selected ions dynamically excluded for 60 s. Ions with singly and unrecognized charge state were also excluded. The LTQ-Orbitrap data were acquired at the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry, Academia Sinica, Nangang District, Taipei City, Taiwan.

3.4.3. Tandem MS Data Analysis of Proteins and Peptide Identification

First, the MS raw data was converted to PKL files using de novo sequencing parameter in the ProteinLynx software coupled with Mascot MS/MS ion search (http://140.112.52.63/mascot/cgi/search_form.pl?FORMVER=2;SEARCH=MIS) [57]. MS/MS data were examined using the National Center for Biotechnology Information (NCBI) database (https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/) accessed on March 15, 2018 [58] for Viridiplantae (green plants) entries. Search parameters were set to: Carbamidomethyl cysteine as fixed modification; oxidation (M) as variable modification; 10 ppm peptide mass tolerance; 2+, 3+, 4+ peptide charge; ± 0.6 Da MS/MS tolerance; instrument is ESI-TRAP; and the enzyme entry as trypsin with 2 missed cleavages. Peptide masses were acquired as monoisotopic masses.
The Mascot ion score was −10*Log (P), where P is the probability that the observed match is a random event. Individual ion scores of N 45 indicated identity or extensive homology (p < 0.05). Protein scores were derived from ion scores as a non-probabilistic basis for ranking protein hits (Matrix Science, London, United Kingdom). The sequence coverage of protein hits was expressed in percentage (%) indicating the sequence homology of identified tryptic peptides from C. sorokiniana to corresponding protein hits based on the Mascot MS/MS ion search results [21].

3.4.4. In Silico Analysis of Bioactive Peptides and Enzyme Cleavages using BIOPEP-UWM Database Tools

Sequences of the identified protein of C. sorokiniana proteins from NCBI database were analyzed for bioactive peptides and enzyme cleavages using BIOPEP-UWM database (http://www.uwm.edu.pl/biochemia/index.php/pl/biopep) accessed on March 15, 2018 [23] performed as described by Cheung et al. [25] with modifications. Briefly, the bioactivities, sequences, number and location of the peptides were obtained from the sequences of the identified proteins analyzed using the “profiles of potential bioactivity” tool. Moreover, the sequences of the identified proteins were examined using the “enzyme action” tool to simulate enzymatic hydrolysis. A total of 15 enzymatic hydrolysis simulations (composed of 12 individual proteases, one double enzyme action, and two triple enzyme action) were conducted to each protein sequence. A list of all the potential bioactive peptides was obtained after directing the theoretical peptide sequence data to the “search for active fragments” option. The occurrence of the frequency of the bioactive peptides in the intact proteins was computed as A = a/N, where A is occurrence frequency, a is the number of bioactive peptides and N is the total number of amino acid residues in the protein sequence.

4. Conclusions

Proteomics techniques coupled with in silico analysis used in this study showed a rapid method to identify the isolated proteins of C. sorokiniana, to predict potential bioactivities and to determine the appropriate proteases that theoretically released more bioactive peptides. Results of the proteomics technique showed the identification of tryptic peptides corresponding to eight proteins from the microalgae. The in silico analysis using BIOPEP-UWM database tools revealed that the combined actions of mixed enzymes and the use of single enzyme action of pepsin (pH > 2) could lead to the production of more diverse and larger numbers of potential bioactive peptides embedded in the protein sequences. According to the results, C. sorokiniana proteins are potential sources of bioactive peptides with various bioactivities. Nonetheless, with the use of appropriate extraction methods and purification techniques for certain predicted bioactivities, these proteins could be a good alternative source of high value compounds for pharmaceutical, medical, cosmetics and functional food applications to aid in human health maintenance and enhancement.

Author Contributions

Conceptualization, L.A.T., J.P.P., E.E.S.Y. and Y.-W.C.; methodology, L.A.T.; validation, L.A.T.; formal analysis, L.A.T.; investigation, L.A.T.; resources, L.A.T. and Y.-W.C.; data curation, L.A.T., J.P.P., E.E.S.Y. and Y.-W.C.; writing—original draft preparation, L.A.T.; writing—review and editing, F.C.A.P.; visualization, L.A.T.; supervision, J.P.P. and Y.-W.C.; funding acquisition, J.P.P. and Y.-W.C.

Funding

This research was funded by the Ministry of Science and Technology, Taiwan (MOST: 106-2311-B-019-001).

Acknowledgments

We thank Taiwan Chlorella Manufacturing Co., Ltd. (Taipei, Taiwan) for the donations of C. sorokiniana biomass samples used in this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Spolaore, P.; Joannis-Cassan, C.; Duran, E.; Isambert, A. Commercial applications of microalgae. J. Biosci. Bioeng. 2006, 101, 87–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Mubarak, M.; Shaija, A.; Suchithra, T. A review on the extraction of lipid from microalgae for biodiesel production. Algal Res. 2015, 7, 117–123. [Google Scholar] [CrossRef]
  3. Schwenzfeier, A.; Wierenga, P.A.; Gruppen, H. Isolation and characterization of soluble protein from the green microalgae Tetraselmis sp. Bioresour. Technol. 2011, 102, 9121–9127. [Google Scholar] [CrossRef] [PubMed]
  4. Zhu, Q.; Chen, X.; Wu, J.; Zhou, Y.; Qian, Y.; Fang, M.; Xie, J.; Wei, D. Dipeptidyl peptidase IV inhibitory peptides from Chlorella vulgaris: In silico gastrointestinal hydrolysis and molecular mechanism. Eur. Food Res. Technol. 2017, 243, 1739–1748. [Google Scholar] [CrossRef]
  5. Kralovec, J.; Metera, K.; Kumar, J.; Watson, L.; Girouard, G.; Guan, Y.; Carr, R.; Barrow, C.; Ewart, H. Immunostimulatory principles from Chlorella pyrenoidosa—Part 1: Isolation and biological assessment in vitro. Phytomedicine 2007, 14, 57–64. [Google Scholar] [CrossRef] [PubMed]
  6. Reyna-Martinez, R.; Gomez-Flores, R.; López-Chuken, U.; Quintanilla-Licea, R.; Caballero-Hernandez, D.; Rodríguez-Padilla, C.; Beltrán-Rocha, J.C.; Tamez-Guerra, P. Antitumor activity of Chlorella sorokiniana and Scenedesmus sp. microalgae native of Nuevo León State, México. PeerJ 2018, 6, e4358. [Google Scholar] [CrossRef] [PubMed]
  7. Sheih, I.-C.; Fang, T.J.; Wu, T.-K. Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste. Food Chem. 2009, 115, 279–284. [Google Scholar] [CrossRef]
  8. Suetsuna, K.; Chen, J.-R. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar. Biotechnol. 2001, 3, 305–309. [Google Scholar] [CrossRef] [PubMed]
  9. Samarakoon, K.W.; Kwon, O.-N.; Ko, J.-Y.; Lee, J.-H.; Kang, M.-C.; Kim, D.; Lee, J.B.; Lee, J.-S.; Jeon, Y.-J. Purification and identification of novel angiotensin-I converting enzyme (ACE) inhibitory peptides from cultured marine microalgae (Nannochloropsis oculata) protein hydrolysate. J. Appl. Phycol. 2013, 25, 1595–1606. [Google Scholar] [CrossRef]
  10. Kang, K.-H.; Qian, Z.-J.; Ryu, B.; Kim, D.; Kim, S.-K. Protective effects of protein hydrolysate from marine microalgae Navicula incerta on ethanol-induced toxicity in HepG2/CYP2E1 cells. Food Chem. 2012, 132, 677–685. [Google Scholar] [CrossRef]
  11. Ko, S.-C.; Kim, D.; Jeon, Y.-J. Protective effect of a novel antioxidative peptide purified from a marine Chlorella ellipsoidea protein against free radical-induced oxidative stress. Food Chem. Toxicol. 2012, 50, 2294–2302. [Google Scholar] [CrossRef] [PubMed]
  12. Vo, T.-S.; Ryu, B.; Kim, S.-K. Purification of novel anti-inflammatory peptides from enzymatic hydrolysate of the edible microalgal Spirulina maxima. J. Funct. Foods 2013, 5, 1336–1346. [Google Scholar] [CrossRef]
  13. Sun, Y.; Chang, R.; Li, Q.; Li, B. Isolation and characterization of an antibacterial peptide from protein hydrolysates of Spirulina platensis. Eur. Food Res. Technol. 2016, 242, 685–692. [Google Scholar] [CrossRef]
  14. Lin, Y.-H.; Chen, G.-W.; Yeh, C.; Song, H.; Tsai, J.-S. Purification and Identification of Angiotensin I-Converting Enzyme Inhibitory Peptides and the Antihypertensive Effect of Chlorella sorokiniana Protein Hydrolysates. Nutrients 2018, 10, 1397. [Google Scholar] [CrossRef] [PubMed]
  15. Morgese, M.; Mhillaj, E.; Francavilla, M.; Bove, M.; Morgano, L.; Tucci, P.; Trabace, L.; Schiavone, S. Chlorella sorokiniana extract improves short-term memory in rats. Molecules 2016, 21, 1311. [Google Scholar] [CrossRef] [PubMed]
  16. Talero, E.; García-Mauriño, S.; Ávila-Román, J.; Rodríguez-Luna, A.; Alcaide, A.; Motilva, V. Bioactive compounds isolated from microalgae in chronic inflammation and cancer. Mar. Drugs 2015, 13, 6152–6209. [Google Scholar] [CrossRef] [PubMed]
  17. Gevaert, K.; Vandekerckhove, J. Protein identification methods in proteomics. ELECTROPHORESIS Int. J. 2000, 21, 1145–1154. [Google Scholar] [CrossRef]
  18. Chang, Y.-W.; Alli, I.; Konishi, Y.; Ziomek, E. Characterization of protein fractions from chickpea (Cicer arietinum L.) and oat (Avena sativa L.) seeds using proteomic techniques. Food Res. Int. 2011, 44, 3094–3104. [Google Scholar] [CrossRef]
  19. Mazzeo, M.F.; Giulio, B.D.; Guerriero, G.; Ciarcia, G.; Malorni, A.; Russo, G.L.; Siciliano, R.A. Fish authentication by MALDI-TOF mass spectrometry. J. Agric. Food Chem. 2008, 56, 11071–11076. [Google Scholar] [CrossRef]
  20. Böhme, K.; Fernández-No, I.C.; Barros-Velázquez, J.; Gallardo, J.M.; Cañas, B.; Calo-Mata, P. Rapid species identification of seafood spoilage and pathogenic Gram-positive bacteria by MALDI-TOF mass fingerprinting. Electrophoresis 2011, 32, 2951–2965. [Google Scholar] [CrossRef] [PubMed]
  21. Huang, B.-B.; Lin, H.-C.; Chang, Y.-W. Analysis of proteins and potential bioactive peptides from tilapia (Oreochromis spp.) processing co-products using proteomic techniques coupled with BIOPEP database. J. Funct. Foods 2015, 19, 629–640. [Google Scholar] [CrossRef]
  22. Jao, C.-L.; Hung, C.-C.; Tung, Y.-S.; Lin, P.-Y.; Chen, M.-C.; Hsu, K.-C. The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes. Biomedicine 2015, 5, 14. [Google Scholar] [CrossRef]
  23. Minkiewicz, P.; Dziuba, J.; Iwaniak, A.; Dziuba, M.; Darewicz, M. BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 2008, 91, 965–980. [Google Scholar]
  24. Kumar, C.; Mann, M. Bioinformatics analysis of mass spectrometry-based proteomics data sets. FEBS Lett. 2009, 583, 1703–1712. [Google Scholar] [CrossRef] [Green Version]
  25. Cheung, I.W.; Nakayama, S.; Hsu, M.N.; Samaranayaka, A.G.; Li-Chan, E.C. Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses. J. Agric. Food Chem. 2009, 57, 9234–9242. [Google Scholar] [CrossRef]
  26. Gangopadhyay, N.; Wynne, K.; O’Connor, P.; Gallagher, E.; Brunton, N.P.; Rai, D.K.; Hayes, M. In silico and in vitro analyses of the angiotensin-I converting enzyme inhibitory activity of hydrolysates generated from crude barley (Hordeum vulgare) protein concentrates. Food Chem. 2016, 203, 367–374. [Google Scholar] [CrossRef]
  27. Lafarga, T.; O’Connor, P.; Hayes, M. Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides 2014, 59, 53–62. [Google Scholar] [CrossRef]
  28. Waghmare, A.G.; Salve, M.K.; LeBlanc, J.G.; Arya, S.S. Concentration and characterization of microalgae proteins from Chlorella pyrenoidosa. Bioresour. Bioprocess. 2016, 3, 16. [Google Scholar] [CrossRef]
  29. Rosenberg, J.N.; Kobayashi, N.; Barnes, A.; Noel, E.A.; Betenbaugh, M.J.; Oyler, G.A. Comparative analyses of three Chlorella species in response to light and sugar reveal distinctive lipid accumulation patterns in the microalga C. sorokiniana. PLoS ONE 2014, 9, e92460. [Google Scholar] [CrossRef]
  30. Watson, H.; Walker, N.; Shaw, P.; Bryant, T.; Wendell, P.; Fothergill, L.; Perkins, R.; Conroy, S.; Dobson, M.; Tuite, M. Sequence and structure of yeast phosphoglycerate kinase. EMBO J. 1982, 1, 1635–1640. [Google Scholar] [CrossRef]
  31. Banks, R.; Blake, C.; Evans, P.; Haser, R.; Rice, D.; Hardy, G.; Merrett, M.; Phillips, A. Sequence, structure and activity of phosphoglycerate kinase: A possible hinge-bending enzyme. Nature 1979, 279, 773–777. [Google Scholar] [CrossRef]
  32. Shevchenko, A.; Tomas, H.; Havli, J.; Olsen, J.V.; Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006, 1, 2856–2860. [Google Scholar] [CrossRef]
  33. Wysocki, V.H.; Resing, K.A.; Zhang, Q.; Cheng, G. Mass spectrometry of peptides and proteins. Methods 2005, 35, 211–222. [Google Scholar] [CrossRef]
  34. Power, O.; Nongonierma, A.B.; Jakeman, P.; FitzGerald, R.J. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes. Proc. Nutr. Soc. 2014, 73, 34–46. [Google Scholar] [CrossRef]
  35. Boots, J.-W.P. Protein Hydrolysate Enriched in Peptides Inhibiting DPP IV and Their Use. U.S. Patent No. 8,273,710, 25 September 2012. [Google Scholar]
  36. Lambeir, A.-M.; Durinx, C.; Scharpé, S.; De Meester, I. Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 2003, 40, 209–294. [Google Scholar] [CrossRef]
  37. Liu, R.; Zhou, L.; Zhang, Y.; Sheng, N.-J.; Wang, Z.-K.; Wu, T.-Z.; Wang, X.-Z.; Wu, H. Rapid Identification of Dipeptidyl Peptidase-IV (DPP IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate. Molecules 2017, 22, 1714. [Google Scholar] [CrossRef]
  38. Lacroix, I.M.; Li-Chan, E.C. Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. J. Funct. Foods 2012, 4, 403–422. [Google Scholar] [CrossRef]
  39. Nongonierma, A.B.; FitzGerald, R.J. An in silico model to predict the potential of dietary proteins as sources of dipeptidyl peptidase IV (DPP IV) inhibitory peptides. Food Chem. 2014, 165, 489–498. [Google Scholar] [CrossRef]
  40. Nongonierma, A.B.; Mooney, C.; Shields, D.C.; FitzGerald, R.J. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP IV) inhibitors. Peptides 2014, 57, 43–51. [Google Scholar] [CrossRef]
  41. Kim, Y.K.; Chung, B.H. A novel angiotensin-I-converting enzyme inhibitory peptide from human αs1-casein. Biotechnol. Lett. 1999, 21, 575–578. [Google Scholar] [CrossRef]
  42. Kohmura, M.; Nio, N.; Kubo, K.; Minoshima, Y.; Munekata, E.; Ariyoshi, Y. Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein. Agric. Biol. Chem. 1989, 53, 2107–2114. [Google Scholar] [CrossRef]
  43. Li, C.H.; Matsui, T.; Matsumoto, K.; Yamasaki, R.; Kawasaki, T. Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein. J. Pept. Sci. 2002, 8, 267–274. [Google Scholar] [CrossRef]
  44. Maruyama, S.; Mitachi, H.; Awaya, J.; Kurono, M.; Tomizuka, N.; Suzuki, H. Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of αs1-casein. Agric. Biol. Chem. 1987, 51, 2557–2561. [Google Scholar] [CrossRef]
  45. Miyoshi, S.; Ishikawa, H.; Kaneko, T.; Fukui, F.; Tanaka, H.; Maruyama, S. Structures and activity of angiotensin-converting enzyme inhibitors in an α-zein hydrolysate. Agric. Biol. Chem. 1991, 55, 1313–1318. [Google Scholar] [CrossRef]
  46. Li, G.-H.; Le, G.-W.; Shi, Y.-H.; Shrestha, S. Angiotensin I–converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr. Res. 2004, 24, 469–486. [Google Scholar] [CrossRef]
  47. Abdelhedi, O.; Nasri, R.; Jridi, M.; Mora, L.; Oseguera-Toledo, M.E.; Aristoy, M.-C.; Amara, I.B.; Toldrá, F.; Nasri, M. In silico analysis and antihypertensive effect of ACE-inhibitory peptides from smooth-hound viscera protein hydrolysate: Enzyme-peptide interaction study using molecular docking simulation. Process Biochem. 2017, 58, 145–159. [Google Scholar] [CrossRef]
  48. Bleakley, S.; Hayes, M.; O’Shea, N.; Gallagher, E.; Lafarga, T. Predicted Release and Analysis of Novel ACE-I, Renin, and DPP IV Inhibitory Peptides from Common Oat (Avena sativa) Protein Hydrolysates Using in Silico Analysis. Foods 2017, 6, 108. [Google Scholar] [CrossRef]
  49. Muhammad, S.A.; Fatima, N. In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn. Mag. 2015, 11, S123–S126. [Google Scholar] [CrossRef]
  50. Paiva, L.; Lima, E.; Neto, A.I.; Baptista, J. Isolation and characterization of angiotensin I-converting enzyme (ACE) inhibitory peptides from Ulva rigida C. Agardh protein hydrolysate. J. Funct. Foods 2016, 26, 65–76. [Google Scholar] [CrossRef]
  51. Kang, K.-H.; Qian, Z.-J.; Ryu, B.; Kim, S.-K. Characterization of growth and protein contents from microalgae Navicula incerta with the investigation of antioxidant activity of enzymatic hydrolysates. Food Sci. Biotechnol. 2011, 20, 183–191. [Google Scholar] [CrossRef]
  52. Sheih, I.-C.; Wu, T.-K.; Fang, T.J. Antioxidant properties of a new antioxidative peptide from algae protein waste hydrolysate in different oxidation systems. Bioresour. Technol. 2009, 100, 3419–3425. [Google Scholar] [CrossRef]
  53. Parimi, N.S.; Singh, M.; Kastner, J.R.; Das, K.C.; Forsberg, L.S.; Azadi, P. Optimization of protein extraction from Spirulina platensis to generate a potential co-product and a biofuel feedstock with reduced nitrogen content. Front. Energy Res. 2015, 3, 30. [Google Scholar] [CrossRef]
  54. Markwell, M.A.K.; Haas, S.M.; Bieber, L.; Tolbert, N. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87, 206–210. [Google Scholar] [CrossRef]
  55. Schägger, H.; Von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166, 368–379. [Google Scholar] [CrossRef]
  56. Rosenfeld, J.; Capdevielle, J.; Guillemot, J.C.; Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis. Anal. Biochem. 1992, 203, 173–179. [Google Scholar] [CrossRef]
  57. Perkins, D.N.; Pappin, D.J.; Creasy, D.M.; Cottrell, J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. ELECTROPHORESIS Int. J. 1999, 20, 3551–3567. [Google Scholar] [CrossRef]
  58. Pruitt, K.D.; Tatusova, T.; Maglott, D.R. NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2006, 35, D61–D65. [Google Scholar] [CrossRef]
Figure 1. Twelve percent SDS-PAGE of C. sorokiniana protein isolates. M: Protein marker; CSPI: C. sorokiniana protein isolate.
Figure 1. Twelve percent SDS-PAGE of C. sorokiniana protein isolates. M: Protein marker; CSPI: C. sorokiniana protein isolate.
Ijms 20 01786 g001
Figure 2. NanoLC–nanoESI MS/MS spectra (m/z region 350–1600) of C. sorokiniana protein band D, m/z 1053.401 signal in red box. Insert A presents the identified doubly charged signal by the difference of 0.50 between signals. Insert B illustrates the fragmentation of nanoLC–nanoESI MS/MS spectra of the peptide NFNNIEDGFYISPAFLDK, calculated MW 2102.99 Da.
Figure 2. NanoLC–nanoESI MS/MS spectra (m/z region 350–1600) of C. sorokiniana protein band D, m/z 1053.401 signal in red box. Insert A presents the identified doubly charged signal by the difference of 0.50 between signals. Insert B illustrates the fragmentation of nanoLC–nanoESI MS/MS spectra of the peptide NFNNIEDGFYISPAFLDK, calculated MW 2102.99 Da.
Ijms 20 01786 g002
Figure 3. NanoLC–nanoESI MS/MS spectra (m/z region 350–1600) of C. sorokiniana protein band D, m/z 618.66 signal in red box. Insert A shows the identified doubly charged signal by the difference of 0.33 between signals. Insert B illustrates the fragmentation of nanoLC–nanoESI MS/MS spectra of the peptide LVDAFPGQSIDFFGALR, calculated MW 1851.95 Da.
Figure 3. NanoLC–nanoESI MS/MS spectra (m/z region 350–1600) of C. sorokiniana protein band D, m/z 618.66 signal in red box. Insert A shows the identified doubly charged signal by the difference of 0.33 between signals. Insert B illustrates the fragmentation of nanoLC–nanoESI MS/MS spectra of the peptide LVDAFPGQSIDFFGALR, calculated MW 1851.95 Da.
Ijms 20 01786 g003
Figure 4. Protein sequence and potential bioactive peptides of chloroplast rubisco activase (AEL29575.1) from C. sorokiniana. Abbreviation: ACE Inhibitory (ACE), Antioxidant (AO), Anti-amnestic (AA), Antithrombotic (AT), Stimulating (S), Regulating (R), DPP IV inhibitory (DPP).
Figure 4. Protein sequence and potential bioactive peptides of chloroplast rubisco activase (AEL29575.1) from C. sorokiniana. Abbreviation: ACE Inhibitory (ACE), Antioxidant (AO), Anti-amnestic (AA), Antithrombotic (AT), Stimulating (S), Regulating (R), DPP IV inhibitory (DPP).
Ijms 20 01786 g004
Figure 5. Protein sequence and potential bioactive peptides of phosphoglycerate kinase (AKP17751.1) from C. sorokiniana. Abbreviation: ACE Inhibitory (ACE), Antioxidant (AO), Anti-amnestic (AA), Antithrombotic (AT), Stimulating (S), Regulating (R), DPP IV inhibitory (DPP).
Figure 5. Protein sequence and potential bioactive peptides of phosphoglycerate kinase (AKP17751.1) from C. sorokiniana. Abbreviation: ACE Inhibitory (ACE), Antioxidant (AO), Anti-amnestic (AA), Antithrombotic (AT), Stimulating (S), Regulating (R), DPP IV inhibitory (DPP).
Ijms 20 01786 g005
Table 1. Identified C. sorokiniana proteins by SDS-PAGE and nanoLC–nanoESI MS/MS analysis.
Table 1. Identified C. sorokiniana proteins by SDS-PAGE and nanoLC–nanoESI MS/MS analysis.
Protein NameAccession Number (NCBI)ScoreSequence Coverage (%)Length (AA)Molecular Weights from NCBI Database (kDa)Molecular Weights (kDa) Estimated from SDS–PAGE
Chloroplast Rubisco ActivaseAEL29575.132331%56745.6845.72 (D)
109.02 (A)
72.08 (B)
38.33 (E)
29.04 (F)
24.96 (G)
21.13 (H)
16.59 (I)
7.82 (J)
50S Ribosomal Protein L7/L12 (Chloroplast)YP_009020879.17218%13013.587.82 (J)
Phosphoglycerate KinaseAKP17751.125022%46549.1345.72 (D)
109.02 (A)
72.08 (B)
54.15 (C)
38.33 (E)
29.04 (F)
24.96 (G)
21.13 (H)
16.59 (I)
7.82 (J)
Fe-superoxide DismutaseAHD25899.1828%23626.4124.96 (G)
Heat Shock Protein 70AKP17750.112829%65271.5572.08 (B)
109.02 (A)
54.15 (C)
38.33 (E)
ATP Synthase Subunit Beta (Chloroplast)YP_009020893.190649%48151.83354.15 (C)
elongation factor 2, partialBAE48222.11204%81690.5445.72 (D)
7.82 (J)
V-type H+ ATPase Subunit A, partialBAE48224.1614%59665.477.82 (J)
Table 2. Number of potential bioactive peptides of identified C. sorokiniana proteins using BIOPEP’s “profiles of potential biological activities” tool.
Table 2. Number of potential bioactive peptides of identified C. sorokiniana proteins using BIOPEP’s “profiles of potential biological activities” tool.
Protein NameNumber of Bioactive Peptides
ACAOAAATSRDPP
Chloroplast Rubisco Activase187 (0.329)18 (0.032)3 (0.005)2 (0.004)14 (0.25)3 (0.005)250 (0.441)
50s Ribosomal Protein L7/L12 (Chloroplast)59 (0.454)8 (0.062)1 (0.008)1 (0.008)8 (0.062)1 (0.008)83 (0.638)
Phosphoglycerate Kinase224 (0.482)23 (0.049)5 (0.011)4 (0.009)33 (0.071)6 (0.013)297 (0.639)
Fe-Superoxide Dismutase107 (0.453)18 (0.076)--5 (0.021)-156 (0.661)
Heat Shock Protein 70276 (0.423)30 (0.046)4 (0.006)4 (0.006)41 (0.064)4 (0.006)446 (0.684)
ATP Synthase Subunit Beta (Chloroplast)204 (0.424)20 (0.042)5 (0.010)5 (0.010)25 (0.052)6 (0.12)332 (0.690)
Abbreviation: ACE Inhibitory (AC), antioxidant (AO), anti-amnestic (AA), antithrombotic (AT), stimulating (S), regulating (R), dipeptidyl peptidase-IV (DPP IV) inhibitory (DPP).
Table 3. Number of predicted potential bioactive peptides to be released from identified proteins of C. sorokiniana using BIOPEP’s “enzyme action” tool.
Table 3. Number of predicted potential bioactive peptides to be released from identified proteins of C. sorokiniana using BIOPEP’s “enzyme action” tool.
ProteaseChloroplast Rubisco ActivasePhosphoglycerate KinaseHeat Shock Protein 70ATP Synthase Subunit Beta
ACAOSDPACAOSDPACAOSDPACAOSDP
Pepsin (EC 3.4.23.1)31224829-5514211178446966
Thermolysin (EC 3.4.24.27)12--14204-2321--31201-25
Bromelain (EC 3.4.22.32)263136258341363250202437
Chymotrypsin A (EC 3.4.21.1)51110912118221574210
Chymotrypsin C (EC 3.4.21.2)17311614-219206235173425
Pancreatic elastase (EC 3.4.21.36)162-31275-49212-34192-41
Papain (EC 3.4.22.2)313135276231404450271443
Proteinase K (EC 3.4.21.67)121-20171119235-41151-28
Trypsin (EC 3.4.21.4)5--331-35--23--3
Ficin (EC 3.4.22.3)277237228333264335227128
Cathepsin (EC 3.4.21.20)4116711662175316
Subtisilin (EC 3.4.21.62)10421410341895724122623
Pepsin + Trypsin2842553315563621066406962
Pepsin + Trysin + Chymotrypsin A3141403315543411063385961
Pepsin + Trysin + Chymotrypsin C2841333514544121070385951
Abbreviation: ACE Inhibitory (AC), Antioxidant (AO), Stimulating (S), DPP IV inhibitory (DP).

Share and Cite

MDPI and ACS Style

Tejano, L.A.; Peralta, J.P.; Yap, E.E.S.; Panjaitan, F.C.A.; Chang, Y.-W. Prediction of Bioactive Peptides from Chlorella sorokiniana Proteins Using Proteomic Techniques in Combination with Bioinformatics Analyses. Int. J. Mol. Sci. 2019, 20, 1786. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20071786

AMA Style

Tejano LA, Peralta JP, Yap EES, Panjaitan FCA, Chang Y-W. Prediction of Bioactive Peptides from Chlorella sorokiniana Proteins Using Proteomic Techniques in Combination with Bioinformatics Analyses. International Journal of Molecular Sciences. 2019; 20(7):1786. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20071786

Chicago/Turabian Style

Tejano, Lhumen A., Jose P. Peralta, Encarnacion Emilia S. Yap, Fenny Crista A. Panjaitan, and Yu-Wei Chang. 2019. "Prediction of Bioactive Peptides from Chlorella sorokiniana Proteins Using Proteomic Techniques in Combination with Bioinformatics Analyses" International Journal of Molecular Sciences 20, no. 7: 1786. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20071786

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop